4:00 - 5:30pm [CEST]
This webinar will provide updates on the latest global STIs trends, the state of Doxy post-exposure prophylaxis (PEP), DoxyPEP and women, vaccines for gonorrhoea, and the citywide impact of DoxyPEP rollout, using San Francisco as an example.
Moderators:
- Renata Sanders, Chief of Craig-Dalsimer Division of Adolescent Medicine, Professor of Paediatrics and Medicine at The Children’s Hospital of Philadelphia, and IAS Governing Council member
- Rodney Perkins, Research Scientist of DoxyPEP Study, University of Washington
Confirmed speakers include:
- Angelica Espinosa, Programme Director of Health and Environmental Surveillance Secretariat, Ministry of Health, Brazil
- Chase Cannon, Medical Director of the Public Health Seattle and King County STD Clinic, University of Washington, USA
- Felix Mogaka, Clinical Research Scientist at Kenya Medical Research Institute, Kenya
- Sinead Delany-Moretlwe, Director of Research at Wits RHI and Professor of Global Health and Infectious Diseases, University of the Witwatersrand, South Africa
- Stephanie Cohen, Medical Director of San Francisco City Clinic and Director of STI Prevention and Control, San Francisco Department of Public Health, USA